Results

Total Results: 46 records

Showing results for "anticoagulant prophylaxis".

41. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
    June 01, 2010 - However, we more clearly identify where on the continuum of prophylaxis-treatment-end-stage these studies … While some studies might hint towards an early intervention (e.g., in prophylaxis use) in high-risk

42. Assessing the Accuracy of Google Translate To Allow Data Extraction From Trials Published in Non-English Languages (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/data-extraction-google_research.pdf
    January 01, 2013 - Cardiac function Colorectal cancer Diabetes mellitus education Diabetes mellitus prevention Fungal prophylaxis … [Comparison of micafungin and fosfluconazole as prophylaxis for invasive fungal infection during neutropenia … Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT

43. Horizon Scanning_Rapid Cost Analyses of Selected Potential High-Impact Intervention Reports (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
    January 01, 2015 - estimated 2.7 million to 6.1 million patients who currently have AF have one or more contraindications to anticoagulants … About half of the patients with contraindications to anticoagulants (550,000 to 1.2 million) are at … expected to be diagnosed each year, and if 40% (64,000) of these new cases have contraindications to anticoagulants … Centers for Disease Control and Prevention (CDC) recommends pre-exposure prophylaxis (PrEP) for males

44. CERs Report cover (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
    September 01, 2010 - of strategies to optimize benefits and minimize harms, such as the concurrent use of a SERM and an anticoagulant … Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence … Future trials could evaluate the benefits and harms of using tamoxifen or raloxifene with an anticoagulant

45. Future Research Needs Document (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
    October 25, 2010 - of strategies to optimize benefits and minimize harms, such as the concurrent use of a SERM and an anticoagulant … Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence of … Future trials could evaluate the benefits and harms of using tamoxifen or raloxifene with an anticoagulant

46. Methods-Balancing-Harms-Benefits Research-2012 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-balancing-harms-benefits_research-2012.pdf
    January 01, 2012 - Unless researchers know the harms of an intervention a priori (e.g., bleeding with anticoagulants), … the American College of Chest Physicians present NNTs based on a systematic review of RCTs of oral anticoagulant … Advances in risk-benefit evaluation using probabilistic simulation methods: an application to the prophylaxis